An Act to reduce the risks associated with allergic reactions
Senate: Accompanied a study order, see S2972
Email me when S 1478 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 1478. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill lets private businesses and other entities obtain epinephrine auto‑injectors and provide them for immediate self‑administration or by trained staff when someone appears to be having anaphylaxis, even if they have no prescription. It also gives those entities protection from ordinary negligence lawsuits and requires the Department of Public Health to create regulations on training, incident reporting, and annual public reports. The goal is to reduce the risk of severe allergic reactions in public places.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 1478
3 free questions a day, no accountHearings
- Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.Joint Committee on Public Health · Jun 11, 2025
History
- Accompanied a study order, see S2972
- Bill reported favorably by committee and referred to the committee on Health Care Financing
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Referred to the committee on Public Health
- House concurred
Sponsors
- William N. Brownsberger · sponsor
- Patrick Joseph Kearney
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 1478 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 1478 freeOr ask your AI assistant about S 1478 directly:
Add to Claude, ChatGPT or Cursor